Effect of LVAD on renal function and other outcomes in patients with impaired renal function

被引：0
|
作者：
Howser, R. [1 ]
Butler, J. [2 ]
Freehling, J. K. [1 ]
Pierson, R. N., III [3 ]
机构：
[1] WorldHeart Inc, Oakland, CA USA
[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[3] Univ Maryland, Med Ctr, Baltimore, MD 21201 USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2006年 / 25卷 / 02期
关键词：
D O I：
10.1016/j.healun.2005.11.318
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
306
引用
收藏
页码：S150 / S150
页数：1
相关论文
共 50 条
  • [41] EFFECT OF CEPHALORIDINE ON RENAL FUNCTION IN PATIENTS WITH RENAL FAILURE
    GOWER, PE
    POSTGRADUATE MEDICAL JOURNAL, 1967, S 43 : 92 - &
  • [42] FENOLDOPAM, BUT NOT NITROPRUSSIDE, IMPROVES RENAL-FUNCTION IN SEVERELY HYPERTENSIVE PATIENTS WITH IMPAIRED RENAL-FUNCTION
    SHUSTERMAN, NH
    ELLIOTT, WJ
    WHITE, WB
    AMERICAN JOURNAL OF MEDICINE, 1993, 95 (02): : 161 - 168
  • [43] Effect of impaired renal function and haemodialysis on the pharmacokinetics of aprepitant
    Bergman, AJ
    Marbury, T
    Fosbinder, T
    Swan, S
    Hickey, L
    Bradstreet, TE
    Busillo, J
    Petty, KJ
    Aiyer, KJV
    Constanzer, M
    Huskey, SEW
    Majumdar, A
    CLINICAL PHARMACOKINETICS, 2005, 44 (06) : 637 - 647
  • [44] EFFECT OF CHLORAMPHENICOL ON HAEMOPOIESIS IN PRESENCE OF IMPAIRED RENAL FUNCTION
    WOLTERS, HG
    HOFFLER, D
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1970, 95 (40) : 2019 - +
  • [45] Evaluation of effect of impaired renal function on lamivudine pharmacokinetics
    Bouazza, Naim
    Treluyer, Jean-Marc
    Ghosn, Jade
    Hirt, Deborah
    Benaboud, Sihem
    Foissac, Frantz
    Viard, Jean-Paul
    Urien, Saik
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (04) : 847 - 854
  • [46] EFFECTS OF NADOLOL AND PROPRANOLOL ON RENAL-FUNCTION IN HYPERTENSIVE PATIENTS WITH MODERATELY IMPAIRED RENAL-FUNCTION
    PUN, KK
    YEUNG, CK
    CHAN, MK
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 20 (04) : 401 - 404
  • [47] Effect of Impaired Renal Function and Haemodialysis on the Pharmacokinetics of Aprepitant
    Arthur J. Bergman
    Thomas Marbury
    Trisha Fosbinder
    Suzanne Swan
    Lisa Hickey
    Thomas E. Bradstreet
    John Busillo
    Kevin J. Petty
    Kala-Jyoti Viswanathan Aiyer
    Marvin Constanzer
    Su-Er W. Huskey
    Anup Majumdar
    Clinical Pharmacokinetics, 2005, 44 : 637 - 647
  • [48] PHARMACOKINETICS OF TENOXICAM IN PATIENTS WITH IMPAIRED RENAL-FUNCTION
    HORBER, FF
    GUENTERT, TW
    WEIDEKAMM, E
    HEIZMANN, P
    DESCOEUDRES, C
    FREY, FJ
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 29 (06) : 697 - 701
  • [49] Coronary lesion characteristics in patients with impaired renal function
    Bozbas, Hueseyin
    ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY, 2007, 7 (01): : 49 - 50
  • [50] PHARMACOKINETICS OF RUFLOXACIN IN PATIENTS WITH IMPAIRED RENAL-FUNCTION
    PERRY, G
    MANT, TGK
    MORRISON, PJ
    SACKS, S
    WOODCOOK, J
    WISE, R
    IMBIMBO, BP
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (04) : 637 - 641
12345